PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Nov-2020 Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter 2020 Financial Results Ampio Pharmaceuticals, Inc.
05-Nov-2020 RHÖN-KLINIKUM Aktiengesellschaft: Dr. Christian Höftberger appointed new CEO of RHÖN-KLINIKUM AG RHÖN-KLINIKUM Aktiengesellschaft
05-Nov-2020 Moberg Pharma’s nomination committee appointed Moberg Pharma
05-Nov-2020 4D Pharma to host virtual KOL event reviewing new data presented at the Society for Immunotherapy of Cancer annual meeting 2020 from Live Biotherapeutic MRx0518 clinical programs 4D pharma plc
05-Nov-2020 Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020 Heidelberg Pharma AG
05-Nov-2020 ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution ENPICOM
05-Nov-2020 EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2020 ON 12 NOVEMBER 2020 Evotec SE
05-Nov-2020 Genmab Announces Financial Results for the First Nine Months of 2020 Genmab
05-Nov-2020 Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Subcutaneous Formulation for the Treatment of Patients with Light Chain (AL) Amyloidosis Janssen
05-Nov-2020 GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth Envision Pharma Group
05-Nov-2020 Hikma continues strong 2020 performance and updates full year guidance Hikma
05-Nov-2020 New £2.5m Influenza Challenge Study Contract Win Open Orphan plc (ORPH)
05-Nov-2020 The New Power of the Pharmaceutical Industry: Covid-19 Vaccines and the Social Responsibility of Pharmaceutical Companies Institute for Business Ethics and Sustainable Strategy (IBES)
05-Nov-2020 Lynparza approved in the EU for the treatment of BRCA- mutated metastatic castration-resistant prostate cancer AstraZeneca
05-Nov-2020 Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer AstraZeneca
05-Nov-2020 ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences B3C newswire
05-Nov-2020 MetrioPharm AG: MetrioPharm Announces Publication of Successful MP1032 Preclinical Data in COVID-19 MetrioPharm AG
05-Nov-2020 Forxiga approved in the EU for heart failure AstraZeneca
05-Nov-2020 Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants With Cystic Fibrosis as Early as Four Months of Age Vertex
05-Nov-2020 Tacalyx Appoints Dr. Klaus Schollmeier as Chairman of the Board Tacalyx GmbH